Copyright ©2013 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Hepatol. Jun 27, 2013; 5(6): 302-310
Published online Jun 27, 2013. doi: 10.4254/wjh.v5.i6.302
Management of hepatocellular carcinoma: Enlightening the gray zones
Andrea Mancuso
Andrea Mancuso, Epatologia e Gastroenterologia, Ospedale Niguarda Cà Granda, 20162 Milano, Italy
Andrea Mancuso, Medicina Interna 1, Azienda di Rilievo Nazionale ad Alta Specializzazione, Ospedale Civico, 90127 Palermo, Italy
Author contributions: Mancuso A solely contributed to this paper.
Correspondence to: Andrea Mancuso, MD, Epatologia e Gastroenterologia, Ospedale Niguarda Ca’ Granda, Piazza Maggiore 3, 20162 Milano, Italy.
Telephone: +39-2-64444435 Fax: +39-2-64442895
Received: March 7, 2013
Revised: May 15, 2013
Accepted: May 18, 2013
Published online: June 27, 2013
Core Tip

Core tip: Management of hepatocellular carcinoma (HCC) has been continuously evolving during recent years. The aim of this paper was to review the current knowledge on management of HCC and to enlighten the areas of uncertainty.